dc.contributor.author | Nilsen, Amalie | |
dc.contributor.author | Hanssen, Tove Aminda | |
dc.contributor.author | Lappegård, Knut Tore | |
dc.contributor.author | Eggen, Anne Elise | |
dc.contributor.author | Løchen, Maja-Lisa | |
dc.contributor.author | Selmer, Randi Marie | |
dc.contributor.author | Njølstad, Inger | |
dc.contributor.author | Wilsgaard, Tom | |
dc.contributor.author | Hopstock, Laila Arnesdatter | |
dc.date.accessioned | 2021-11-26T09:21:14Z | |
dc.date.available | 2021-11-26T09:21:14Z | |
dc.date.issued | 2021-08-30 | |
dc.description.abstract | Aims - To compare the population proportion at high risk of cardiovascular disease (CVD) using the Norwegian NORRISK 1 that predicts 10-year risk of CVD mortality and the Norwegian national guidelines from 2009, with the updated NORRISK 2 that predicts 10-year risk of both fatal and non-fatal risk of CVD and the Norwegian national guidelines from 2017.<p>
<p>Methods - We included participants from the Norwegian population-based Tromsø Study (2015–2016) aged 40–69 years without a history of CVD (n=16 566). The total proportion eligible for intervention was identified by NORRISK 1 and the 2009 guidelines (serum total cholesterol ≥8 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg) and NORRISK 2 and the 2017 guidelines (serum total cholesterol ≥7 mmol/L, low density lipoprotein (LDL) cholesterol ≥5 mmol/L, systolic blood pressure ≥160 mm Hg or diastolic blood pressure ≥100 mm Hg).<p>
<p>Results - The total proportion at high risk as defined by a risk score was 12.0% using NORRISK 1 and 9.8% using NORRISK 2. When including single risk factors specified by the guidelines, the total proportion eligible for intervention was 15.5% using NORRISK 1 and the 2009 guidelines and 18.9% using NORRISK 2 and the 2017 guidelines. The lowered threshold for total cholesterol and specified cut-off for LDL cholesterol stand for a large proportion of the increase in population at risk.<p>
<p>Conclusion - The population proportion eligible for intervention increased by 3.4 percentage points from 2009 to 2017 using the revised NORRISK 2 score and guidelines. | en_US |
dc.identifier.citation | Nilsen, Hanssen, Lappegård, Eggen, Løchen, Selmer, Njølstad, Wilsgaard, Hopstock. Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: The Tromsø Study 2015-2016. Open heart. 2021;8:e001777:1-9 | en_US |
dc.identifier.cristinID | FRIDAID 1943387 | |
dc.identifier.doi | 10.1136/openhrt-2021-001777 | |
dc.identifier.issn | 2053-3624 | |
dc.identifier.uri | https://hdl.handle.net/10037/23175 | |
dc.language.iso | eng | en_US |
dc.publisher | BMJ Publishing Group | en_US |
dc.relation.ispartof | Hagen, A.N. (2023). Cardiovascular disease: risk assessment, total risk, and primary prevention in the general population. Insights from the Tromsø Study. (Doctoral thesis). <a href=https://hdl.handle.net/10037/28493>https://hdl.handle.net/10037/28493</a>. | |
dc.relation.journal | Open heart | |
dc.rights.accessRights | openAccess | en_US |
dc.rights.holder | Copyright 2021 The Author(s) | en_US |
dc.subject | VDP::Medical disciplines: 700::Health sciences: 800::Community medicine, Social medicine: 801 | en_US |
dc.subject | VDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801 | en_US |
dc.title | Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: The Tromsø Study 2015-2016 | en_US |
dc.type.version | publishedVersion | en_US |
dc.type | Journal article | en_US |
dc.type | Tidsskriftartikkel | en_US |
dc.type | Peer reviewed | en_US |